Corporates

MD IP advises companies in the chemical and pharmaceutical sectors on obtaining and defending patent protection in Europe.

The firm's work spans patent drafting, prosecution, oppositions, appeals, freedom-to-operate matters and wider patent strategy, with a particular focus on proceedings before the European Patent Office.

Today, MD IP acts for a growing number of domestic and international companies, ranging from innovative businesses developing their first patent portfolios to established organisations managing valuable patent assets across multiple jurisdictions.

Patents are often among a company's most valuable assets. Whether protecting a new technology, defending a granted patent or navigating complex proceedings before the EPO, MD IP focuses on securing robust and commercially meaningful outcomes for its clients.

The practice combines specialist chemistry and pharmaceutical expertise with the standards, judgement and client service culture associated with Europe's leading patent firms.